Pages that link to "Q34617976"
Jump to navigation
Jump to search
The following pages link to Diminished hepatic gluconeogenesis via defects in tricarboxylic acid cycle flux in peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha)-deficient mice (Q34617976):
Displaying 50 items.
- 8-Oxoguanine DNA glycosylase (OGG1) deficiency increases susceptibility to obesity and metabolic dysfunction (Q21090825) (← links)
- Rev-erbalpha, a heme sensor that coordinates metabolic and circadian pathways (Q24300630) (← links)
- The impact of obesity, sex, and diet on hepatic glucose production in cats (Q24644267) (← links)
- Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver (Q24647278) (← links)
- FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response (Q24653481) (← links)
- Fibroblast growth factor 21: from pharmacology to physiology (Q24658126) (← links)
- Mitochondrial adaptations evoked with exercise are associated with a reduction in age-induced testicular atrophy in Fischer-344 rats (Q26823283) (← links)
- Obligate role for ketone body oxidation in neonatal metabolic homeostasis (Q28505766) (← links)
- Differential regulation of PGC-1alpha expression in rat liver and skeletal muscle in response to voluntary running (Q28583037) (← links)
- Disturbed hepatic carbohydrate management during high metabolic demand in medium-chain acyl-CoA dehydrogenase (MCAD)-deficient mice (Q28593686) (← links)
- Demonstration of glucose-6-phosphate hydrogen 5 enrichment from deuterated water by transaldolase-mediated exchange alone (Q30955668) (← links)
- PGC-1alpha negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erb(alpha) axis (Q33564184) (← links)
- Urinary loss of tricarboxylic acid cycle intermediates as revealed by metabolomics studies: an underlying mechanism to reduce lipid accretion by whey protein ingestion? (Q33709740) (← links)
- Thioesterase superfamily member 2 (Them2) and phosphatidylcholine transfer protein (PC-TP) interact to promote fatty acid oxidation and control glucose utilization (Q33743689) (← links)
- NHE1 deficiency in liver: implications for non-alcoholic fatty liver disease. (Q33954199) (← links)
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state (Q33968008) (← links)
- Therapies in inborn errors of oxidative metabolism. (Q34055267) (← links)
- Peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) stimulates VLDL assembly through activation of cell death-inducing DFFA-like effector B (CideB) (Q34074263) (← links)
- Hepatic FoxO1 ablation exacerbates lipid abnormalities during hyperglycemia (Q34094336) (← links)
- Identification of the Aryl Hydrocarbon Receptor Target Gene TiPARP as a Mediator of Suppression of Hepatic Gluconeogenesis by 2,3,7,8-Tetrachlorodibenzo-p-dioxin and of Nicotinamide as a Corrective Agent for This Effect (Q34385994) (← links)
- Inhibiting monoacylglycerol acyltransferase 1 ameliorates hepatic metabolic abnormalities but not inflammation and injury in mice (Q34397051) (← links)
- The molecular and metabolic influence of long term agmatine consumption (Q34403988) (← links)
- Liver-specific PGC-1beta deficiency leads to impaired mitochondrial function and lipogenic response to fasting-refeeding (Q34534313) (← links)
- Liver-specific loss of lipin-1-mediated phosphatidic acid phosphatase activity does not mitigate intrahepatic TG accumulation in mice (Q35217044) (← links)
- Progressive Impairment of Lactate-based Gluconeogenesis in the Huntington's Disease Mouse Model R6/2 (Q35660733) (← links)
- Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver (Q35958436) (← links)
- The cat as a model for human obesity and diabetes (Q36228987) (← links)
- Liver AMP-Activated Protein Kinase Is Unnecessary for Gluconeogenesis but Protects Energy State during Nutrient Deprivation (Q36255938) (← links)
- Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver (Q36335957) (← links)
- Dietary fat is a lipid source in 2,3,7,8-tetrachlorodibenzo-ρ-dioxin (TCDD)-elicited hepatic steatosis in C57BL/6 mice (Q36383651) (← links)
- Metabolic adaptations through the PGC-1 alpha and SIRT1 pathways (Q36510743) (← links)
- CCAAT/enhancer binding protein-beta is a transcriptional regulator of peroxisome-proliferator-activated receptor-gamma coactivator-1alpha in the regenerating liver (Q36756425) (← links)
- Combined pharmacological activation of AMPK and PPARδ potentiates the effects of exercise in trained mice (Q36773746) (← links)
- The transcriptional coactivator PGC-1alpha is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis (Q36807931) (← links)
- Delineation of the key aspects in the regulation of epithelial monolayer formation (Q36978321) (← links)
- Impact of peripheral ketolytic deficiency on hepatic ketogenesis and gluconeogenesis during the transition to birth. (Q37000590) (← links)
- (13)C MRS and LC-MS Flux Analysis of Tumor Intermediary Metabolism (Q37004918) (← links)
- Skeletal muscle PGC-1α modulates systemic ketone body homeostasis and ameliorates diabetic hyperketonemia in mice (Q37146497) (← links)
- Sensitivity of lipid metabolism and insulin signaling to genetic alterations in hepatic peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression (Q37236343) (← links)
- Alterations in hepatic glucose and energy metabolism as a result of calorie and carbohydrate restriction (Q37239757) (← links)
- Nutrient-dependent regulation of PGC-1alpha's acetylation state and metabolic function through the enzymatic activities of Sirt1/GCN5 (Q37652237) (← links)
- The Fox genes in the liver: from organogenesis to functional integration (Q37677914) (← links)
- Hormonal regulation of hepatic glucose production in health and disease (Q37896899) (← links)
- Emerging role of AMP-activated protein kinase in endocrine control of metabolism in the liver (Q38026353) (← links)
- Dissociating fatty liver and diabetes (Q38050214) (← links)
- Selective Chemical Inhibition of PGC-1α Gluconeogenic Activity Ameliorates Type 2 Diabetes. (Q38432412) (← links)
- Loss of Mitochondrial Pyruvate Carrier 2 in the Liver Leads to Defects in Gluconeogenesis and Compensation via Pyruvate-Alanine Cycling (Q38837452) (← links)
- Targeting hepatic glucose metabolism in the treatment of type 2 diabetes (Q38925481) (← links)
- PGC1α promotes tumor growth by inducing gene expression programs supporting lipogenesis. (Q39474407) (← links)
- The role of chicken ovalbumin upstream promoter transcription factor II in the regulation of hepatic fatty acid oxidation and gluconeogenesis in newborn mice (Q41200860) (← links)